Académique Documents
Professionnel Documents
Culture Documents
Drug Interactions
Occurs when either the pharmacokinetics or the pharmacodynamics of one drug is altered by the administration of food or a concomitant drug Factors that can exaggerate pharmacokinetic variability include:
drug-drug interactions drug-food interactions drug-disease interactions (altered GI, renal and hepatic function) Sex differences in patients Pregnancy Genetic differences in patients
PK Interactions
Absorption Distribution Metabolism Excretion
PD Interactions
Antagonistic
AZT + d4T
1+1=0
Synergistic
1+1=3
Hydroxyurea + NRTIs
Additive
Overlapping toxicities
1+1=2
CYP 3A4
Specific enzyme Subfamily Family CYP Substrates GENE for mammalian cytochrome CYP Inducers CYP Inhibitors
3A4
Inhibited by: RTV Induced by: RTV, NFV
Inhibited by: RTV, NFV, IDV, APV, SQV, ATV, DLV Induced by: RTV, NFV
Induced by:
RTV, NFV ?
Induced by:
EFV, NVP
Substrate concentration
Toxicity
Substrate concentration
Efficacy
Source: Henry JA, Hill IR. Fatal interaction between ritonavir and MDMA. Lancet 1998;352:17512.
Use 25% of the usual amount of MDMA Take breaks from dancing
Make sure rave or party has medical team on site Maintain adequate hydration by avoiding alcohol and replenishing fluids regularly
Source: Antoniou T, Tseng AL. Interactions between recreational drugs and antiretroviral agents. Ann Pharmacother 2002 Oct;36(10):1598-613.
Amphetamines (dexedrine, amphetamine, methamphetamine, crystal meth) Amphetamines work the same
way that X does in your body. As with X, Norvir (ritonavir) should be avoided.
Norvir is predicted to increase amphetamine levels in the blood by a factor of 2-3.
The other protease inhibitors should have less of an impact, but strange opposite results are always possible.
GHB,Liquid X
(GABA, -aminobutyric acid, date rape drug) 2D6 substrate GHB is potentially dangerous with ritonavir and other PIs. One man had serious lifethreatening conditions after taking a small amount of GHB to come down from an X trip. He was on ritonavir and saquinavir at the time and had taken similar does of the rave drugs without problems in the past.
Source: Harrington RD, Woodward JA, Hooton TM, Horn JR. Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate. Arch Intern Med 1999;159:22214.
Alcohol
Can reduce effectiveness of HARRT by reducing adherence. Can lead to hepatotoxicity either directly or indirectly by increasing the risk of druginduced hepatotoxicity. Videx (ddI) can increase the risk of pancreatitis. Can AUC of abacavir by 41% and t1/2 by 26%. Clinical significance?
Alcohol
Occasional and light use of alcohol is not known to interact with other HIV medications; however, chronic, heavy use can be destructive to the liver.
Marijuana
3A4,2C9,2C6 substrate Protease inhibitors may increase THC levels (the active ingredient in marijuana)let your patients know that smaller doses may make them more stoned. This is also true of the synthetic version (Marinol) used in the treatment of weight loss.
Mushrooms
(shrooms, boomers, psilocybin)
No known interactions.
Sedatives
The sedatives Halcion (triazolam), Valium (diazepam), Ambiem (zolpidem) and Versed (midazolam) can be deadly if mixed with PIs. Norvir has the largest negative effect. At high doses these drugs can stop your breathing. Ativan (lorazepam), Serax (oxazepam) and Restoril (temazepam) are safer with Norvir, and may actually be weakened by it since they are glucuronidated and norvir glucuronidation.
Barbiturates
Clinicians should avoid co-administration of NNRTIs and phenobarbital. Phenobarbital is a potent inducer of CYP3A4 and so are NNRTIs. Crixivan may increase blood levels of phenobarbital (Luminal), making overdose more likely. Other protease inhibitor interactions are also possible.
Methadone (done)
Interactions between methadone and NNRTIs and PIs are highly likely. Sustiva and Viramune strongly induce the metabolism of methadone (AUC 52% and 46% respectively)and may cause withdrawal in methadone pts. People on methadone maintenance may need higher doses of the opiate. Ritonavir, nelfinavir, and possibly Kaletra may cause similar problems.
Methadone (done)
Methadone increased the AUC of ZDV by 43% and can lead to toxicity. Patients should be monitored for toxicity (i.e. nausea, vomiting, headaches and low blood platelet levels). Methadone may decrease the antiHIV action of Didanosine (AUC 63%) while taking methadone. This could lead to resistance in the virus and the creation of more powerful strains of HIV. Using Videx EC is thought to allow the drugs to pass through the stomach without methadone weakening them.
Buprenorphine
Drug interaction data limited Metabolism was inhibited by PIs (RTV > IDV > SQV) Efavirenz has been shown to reduce buprenorphine plasma concentrations without precipitating withdrawal.
Disulfiram/Naltrexone
Published data limited Naltrexone not likely because it is not metabolized by CYP450 Disulfiram while possible has not been documented.
Consider TDM